Early Weight Loss Responders to Liraglutide 3.0 mg had Greater Weight Loss, Regression to Normoglycemia and Reduced T2D Development at 3 Years vs. Early Non-Responders: SCALE Obesity and Prediabetes
2016 ◽
Vol 40
(5)
◽
pp. S33
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 35
(2)
◽
pp. 153
◽
Keyword(s):
Keyword(s):
Keyword(s):